Report DMCA Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confound
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.